1182O Temozolomide treatment induces an MMR-dependent hypermutator phenotype in well differentiated pancreatic neuroendocrine tumors von de Mestier du Bourg, L., Cohen, D., Masliah-Planchon, J., Sivakumar, S., de rycke, O., Dhome, O. Hentic, Fleischmann, Z., Sokol, E.S., Decker, B., Couvelard, A., Ruszniewski, P., Bieche, I., Cros, J.

Volltext

Anticorps antiphospholipides et hémostase von Masliah-Planchon, J., Darnige, L.

Volltext

Rhabdoid component emerging as a subclonal evolution of paediatric glioneuronal tumours von Bertrand, A., Rondenet, C., Masliah‐Planchon, J., Leblond, P., Fourchardière, A., Pissaloux, D., Aït‐Raïs, K., Lequin, D., Jouvet, A., Freneaux, P., Sevestre, H., Ranchere‐Vince, D., Tauziede‐Espariat, A., Maurage, C.‐A., Silva, K., Pierron, G., Delattre, O., Varlet, P., Frappaz, D., Bourdeaut, F.

Volltext

Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants von Villy, M.-C., Masliah-Planchon, J., Melaabi, S., Trabelsi Grati, O., Girard, E., Bataillon, G., Vincent-Salomon, A., Le Gall, J., Golmard, L., Stoppa-Lyonnet, D., Bieche, I., Colas, C.

Volltext

Review: delta-storage pool disease von Masliah-Planchon, J, Flaujac, C, Tapon-Bretaudière, J, Cramer-Bordé, E M, Darnige, L

Volltext

Mise au point : la maladie du pool vide plaquettaire von MASLIAH-PLANCHON, J, FLAUJAC, C, TAPON-BRETAUDIERE, J, CRAMER-BORDE, E. M, DARNIGE, L

Volltext

Exploration génomique de l’agressivité des tumeurs neuroendocrines hypophysaires (PitNETs) von Benanteur, N., Villa, C., De Murat, D., Birtolo, M.F., Jouinot, A., Letourneur, F., Gaillard, S., Masliah-Planchon, J., Hage-Deconinck, M., Emile, J.F.

Volltext

Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets von Moreira, A., Masliah-Planchon, J., Callens, C., Vacher, S., Lecerf, C., Frelaut, M., Borcoman, E., Torossian, N., Ricci, F., Hescot, S., Sablin, M.P., Tresca, P., Loirat, D., Melaabi, S., Trabelsi-Grati, O., Pierron, G., Gentien, D., Bernard, V., Vincent Salomon, A., Servant, N., Bieche, I., Le Tourneau, C., Kamal, M.

Volltext

SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype von Pasmant, E, Sabbagh, A, Hanna, N, Masliah-Planchon, J, Jolly, E, Goussard, P, Ballerini, P, Cartault, F, Barbarot, S, Landman-Parker, J, Soufir, N, Parfait, B, Vidaud, M, Wolkenstein, P, Vidaud, D, France, R N F

Volltext

Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery von Moreira, A., Poulet, A., Masliah-Planchon, J., Lecerf, C., Vacher, S., Larbi Chérif, L., Dupain, C., Marret, G., Girard, E., Syx, L., Hoffmann, C., Jeannot, E., Klijanienko, J., Guillou, I., Mariani, O., Dubray-Vautrin, A., Badois, N., Lesnik, M., Choussy, O., Calugaru, V., Borcoman, E., Baulande, S., Legoix, P., Albaud, B., Servant, N., Bieche, I., Le Tourneau, C., Kamal, M.

Volltext

Loss of SMARCB1 expression in colon carcinoma von Melloul, S, Mosnier, J-F, Masliah-Planchon, J, Lepage, C, Le Malicot, K, Gornet, J-M, Edeline, J, Dansette, D, Texereau, P, Delattre, O, Laurent Puig, P, Taieb, J, Emile, J-F

Volltext

864P Serial cell-free tumor DNA in prognosing survival in patients with head and neck squamous cell carcinoma treated with upfront surgery von Marret, G., Lamy, C., Vacher, S., Ahmanache, L., Séné, M., Klijanienko, J., Martinat, C., Halladjian, M., Bronzini, T., Balsat, C., Sauvage, S., Martin, E., Rougier, G., Dubray Vautrin, A., Choussy, O., Masliah-Planchon, J., Servant, N., Bieche, I., Le Tourneau, C., Kamal, M.

Volltext

75P Tumor mutational burden in clinical routine practice: Identifying the right threshold? von Dupain, C., Gutman, T., Girard, E., du Rusquec, P., Sablin, M-P., Tresca, P., Neuzillet, C., Vincent-Salomon, A., Antonio, S., Franck, C., Galut, M., Allory, Y., Cyrta, J., Guillou, I., Wong, J., Le Tourneau, C., Bièche, I., Servant, N., Kamal, M., Masliah-Planchon, J.

Volltext

526O High activity of nivolumab in patients with pathogenic exonucleasic domain POLE (edPOLE) mutated Mismatch Repair proficient (MMRp) advanced tumours von Rousseau, B.J-C., Bieche, I., Pasmant, E., Simmet, V., Hamzaoui, N., Masliah-Planchon, J., Pouessel, D., Bruyas, A., Augereau, P., Grob, J-J., Rolland, F., Saada-Bouzid, E., Cohen, R., Bouche, O., Hoog-Labouret, N., Legrand, F., Simon, C., Lamrani-Ghaouti, A., Chevret, S., Marabelle, A.

Volltext

97P - Reanalysis of the efficacy of molecular targeted agents (MTAs) given in the randomized trial SHIVA01 according to the ESMO ESCAT scale of actionability von Moreira, A., Vacher, S., Lecerf, C., Frelaut, M., Sablin, M.P., Loirat, D., Ricci, F., Hescot, S., Borcoman, E., Torossian, N., Masliah-Planchon, J., Callens, C., Salomon, A., Bieche, I., Le Tourneau, C., Kamal, M.

Volltext

Prospective comparative study of next-generation sequencing on fine needle aspirations versus core needle biopsies in cancer patients included in SHIVA02 trial von Masliah-Planchon, J., Kamal, M., Borcoman, E., Girard, E., Gestraud, P., Bataillon, G., Vincent-Salomon, A., Lecerf, C., Callens, C., Antonio, S., Franck, C., Mariani, O., Bieche, I., Le Tourneau, C., Servois, V.

Volltext

103P - Prospective comparative study of next-generation sequencing on fine needle aspirations versus core needle biopsies in cancer patients included in SHIVA02 trial von Masliah-Planchon, J., Kamal, M., Borcoman, E., Girard, E., Gestraud, P., Bataillon, G., Vincent-Salomon, A., Lecerf, C., Callens, C., Antonio, S., Franck, C., Mariani, O., Bieche, I., Le Tourneau, C., Servois, V.

Volltext

Reanalysis of the efficacy of molecular targeted agents (MTAs) given in the randomized trial SHIVA01 according to the ESMO ESCAT scale of actionability von Moreira, A., Vacher, S., Lecerf, C., Frelaut, M., Sablin, M.P., Loirat, D., Ricci, F., Hescot, S., Borcoman, E., Torossian, N., Masliah-Planchon, J., Callens, C., Salomon, A., Bieche, I., Le Tourneau, C., Kamal, M.

Volltext

Medulloblastoma Molecular Subgroup and Hyperfractionated Radiation Therapy Alone for Standard Risk Medulloblastoma : Results of the Pool Data of MSFOP 1998 and 2007 Studies von Carrie, C., Kieffer, V., Figarella-Branger, D., Masliah-Planchon, J., Bolle, S., Leseur, J., Supiot, S., Laprie, A., Bernier, V., Dufour, C., Huchet, A., Coche-Dequeant, B., Truc, G., Vigneron, C., Alapetite, C., Habrand, J.L., Dubray, B.M., Colin, C., Ferlay, C., Padovani, L.

Volltext

À propos d’une série de 33 chordomes pédiatriques : validation du score immunohistopronostique et établissement d’un nouvel algorithme pronostique intégrant le statut SMARCB1... von Tauziède-Espariat, A., Adle-Biassette, H., Polivka, M., Beccaria, K., Puget, S., Laquerrière, A., Sevestre, H., Gauchotte, G., Eimer, S., Masliah-Planchon, J., Varlet, P.

Volltext